118 related articles for article (PubMed ID: 2140865)
1. Additional steps proposed to ensure antiacne drug used only in appropriate patient population.
Marwick C
JAMA; 1990 Jun; 263(23):3125-6. PubMed ID: 2140865
[No Abstract] [Full Text] [Related]
2. How to ensure fetal safety when mothers use isotretinoin (Accutane).
Koren G; Pastuszak A
Can Fam Physician; 1997 Feb; 43():216-9. PubMed ID: 9040906
[No Abstract] [Full Text] [Related]
3. Pregnancy, abortion and the dangers of prescribing vitamin A analogs in Australia.
Lipson T
Australas J Dermatol; 1996 May; 37(2):114-5. PubMed ID: 8687330
[No Abstract] [Full Text] [Related]
4. We Pledge to Change iPLEDGE.
Pierson JC; Ferris LK; Schwarz EB
JAMA Dermatol; 2015 Jul; 151(7):701-2. PubMed ID: 25853235
[No Abstract] [Full Text] [Related]
5. When a uniquely effective drug is teratogenic. The case of isotretinoin.
Stern RS
N Engl J Med; 1989 Apr; 320(15):1007-9. PubMed ID: 2522591
[No Abstract] [Full Text] [Related]
6. Pregnancy and isotretinoin therapy.
Choi JS; Koren G; Nulman I
CMAJ; 2013 Mar; 185(5):411-3. PubMed ID: 23296582
[No Abstract] [Full Text] [Related]
7. [30 years with isotretinoin. "Miracle medicine" against acne with many side effects].
Mobacken H; Sundström A; Vahlquist A
Lakartidningen; 2014 Jan 15-28; 111(3-4):93-6. PubMed ID: 24552013
[No Abstract] [Full Text] [Related]
8. Pregnancy and pregnancy rates in association with isotretinoin (Accutane).
Brinker A; Trontell A; Beitz J
J Am Acad Dermatol; 2002 Nov; 47(5):798-9. PubMed ID: 12399783
[No Abstract] [Full Text] [Related]
9. Does the teratogenicity of isotretinoin outweigh its benefits?
Jordan AY; Parks L; Chen SC; Higgins K; Fleischer AB; Feldman SR
J Dermatolog Treat; 2005; 16(4):190-2. PubMed ID: 16249139
[No Abstract] [Full Text] [Related]
10. FDA ponders approaches to curbing adverse effects of drug used against cystic acne.
Marwick C
JAMA; 1988 Jun; 259(22):3225. PubMed ID: 2967382
[No Abstract] [Full Text] [Related]
11. Safety and side effects of the acne drug, oral isotretinoin.
Charakida A; Mouser PE; Chu AC
Expert Opin Drug Saf; 2004 Mar; 3(2):119-29. PubMed ID: 15006718
[TBL] [Abstract][Full Text] [Related]
12. Isotretinoin use in pregnancy.
Lancaster PA; Rogers JG
Med J Aust; 1988 Jun; 148(12):654-5. PubMed ID: 2967907
[No Abstract] [Full Text] [Related]
13. [Pregnancy after isotretinoin use].
Manders KC; de Vries LC; Roumen FJ
Ned Tijdschr Geneeskd; 2013; 157(41):A6567. PubMed ID: 24103139
[TBL] [Abstract][Full Text] [Related]
14. Isotretinoin, pregnancies, abortions and birth defects: a population-based perspective.
Bérard A; Azoulay L; Koren G; Blais L; Perreault S; Oraichi D
Br J Clin Pharmacol; 2007 Feb; 63(2):196-205. PubMed ID: 17214828
[TBL] [Abstract][Full Text] [Related]
15. Possible long-term teratogenic effect of isotretinoin in pregnancy.
Malvasi A; Tinelli A; Buia A; De Luca GF
Eur Rev Med Pharmacol Sci; 2009; 13(5):393-6. PubMed ID: 19961047
[TBL] [Abstract][Full Text] [Related]
16. Medical complications of isotretinoin.
Ginsberg H; Rubenstein A; Brown WV
Clin Dermatol; 1986; 4(1):183-9. PubMed ID: 2978683
[No Abstract] [Full Text] [Related]
17. Moral dilemma: two views.
Pedulla DM
Postgrad Med; 1986 May; 79(6):34-5. PubMed ID: 2939403
[No Abstract] [Full Text] [Related]
18. Continued occurrence of Accutane-exposed pregnancies.
Honein MA; Paulozzi LJ; Erickson JD
Teratology; 2001 Sep; 64(3):142-7. PubMed ID: 11514944
[TBL] [Abstract][Full Text] [Related]
19. Pregnancy and isotretinoin therapy.
Dumont T; Black A
CMAJ; 2013 Apr; 185(6):508. PubMed ID: 23550056
[No Abstract] [Full Text] [Related]
20. Craniofacial features of isotretinoin embryopathy.
Fernhoff PM; Lammer EJ
J Pediatr; 1984 Oct; 105(4):595-7. PubMed ID: 6237183
[No Abstract] [Full Text] [Related]
[Next] [New Search]